Protein arginine methylation: from enigmatic functions to therapeutic targeting
Protein arginine methyltransferases (PRMTs) are emerging as attractive therapeutic targets.
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …
Protein arginine methyltransferases: promising targets for cancer therapy
JW Hwang, Y Cho, GU Bae, SN Kim… - Experimental & molecular …, 2021 - nature.com
Protein methylation, a post-translational modification (PTM), is observed in a wide variety of
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer
The coactivator associated arginine methyltransferase (CARM1) promotes transcription, as
its name implies. It does so by modifying histones and chromatin bound proteins. We …
its name implies. It does so by modifying histones and chromatin bound proteins. We …
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Q Wang, Y Shi, K Zhou, L Wang, Z Yan, Y Liu… - Cell death & …, 2018 - nature.com
Chemotherapy represents an important treatment option for colorectal cancer (CRC), but
only half of the patients benefit from these regimens. We explored the potential predicting …
only half of the patients benefit from these regimens. We explored the potential predicting …
Cellular consequences of arginine methylation
BM Lorton, D Shechter - Cellular and Molecular Life Sciences, 2019 - Springer
Arginine methylation is a ubiquitous post-translational modification. Three predominant
types of arginine-guanidino methylation occur in Eukarya: mono (Rme1/MMA), symmetric …
types of arginine-guanidino methylation occur in Eukarya: mono (Rme1/MMA), symmetric …
Arginine methylation‐dependent LSD1 stability promotes invasion and metastasis of breast cancer
Abstract Histone lysine demethylase 1 (LSD 1), the first identified histone demethylase, is
overexpressed in multiple tumor types, including breast cancer. However, the mechanisms …
overexpressed in multiple tumor types, including breast cancer. However, the mechanisms …
Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition
Protein arginine methyltransferases (PRMTs) introduce arginine methylation, a post-
translational modification with the increasingly eminent role in normal physiology and …
translational modification with the increasingly eminent role in normal physiology and …
[HTML][HTML] Protein arginine methylation/demethylation and cancer
C Poulard, L Corbo, M Le Romancer - Oncotarget, 2016 - ncbi.nlm.nih.gov
Protein arginine methylation is a common post-translational modification involved in
numerous cellular processes including transcription, DNA repair, mRNA splicing and signal …
numerous cellular processes including transcription, DNA repair, mRNA splicing and signal …
[HTML][HTML] TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
K Nakayama, MM Szewczyk, C dela Sena, H Wu… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Abstract Protein arginine methyltransferase (PRMT) 4 (also known as coactivator-associated
arginine methyltransferase 1; CARM1) is involved in a variety of biological processes and is …
arginine methyltransferase 1; CARM1) is involved in a variety of biological processes and is …